EUVIMEDEUVIMED entdecken
Open Access

Eriocitrin Attenuates Diabetic Cardiomyopathy by Regulating Copper Homeostasis and Cuproptosis‐Associated Pathways via SIRT7/YAP/ATP7A Signalling

Lin Chen, Sixin Mao, Yan Yu, Dingyong Zhang, Zixia Fan iD

Basic & Clinical Pharmacology & Toxicology · 2026-10 · 139 (4)

DOI: 10.1111/bcpt.70301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 15.09.2026. Verfasst von Lin Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Sir Run Shaw Hospital, Zhejiang University School of Medicine, Zhejiang, China. Hauptthemen laut MEDLINE: Copper, Diabetic Cardiomyopathies, Diabetes Mellitus, Experimental, Flavonoids. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic cardiomyopathy (DCM) is a major complication of diabetes mellitus, with limited therapeutic strategies available. Cuproptosis, a novel form of copper‐dependent cell death, has been implicated in cardiac dysfunction but remains unexplored in DCM. Here, we investigated the effects of Eriocitrin, a natural flavonoid, on DCM and examined the potential involvement of copper homeostasis, cuproptosis‐associated molecular alterations and SIRT7/YAP/ATP7A signalling. Using high‐fat diet and streptozotocin‐induced diabetic mice, along with high‐glucose‐treated cardiomyocytes, we demonstrated that Eriocitrin improved cardiac function, attenuated myocardial remodelling and corrected glucose and lipid metabolism. Mechanistically, Eriocitrin improved myocardial copper homeostasis by enhancing ATP7A and ATP7B expression and reducing copper accumulation and cuproptosis‐associated molecular alterations. Loss of SIRT7 impaired these effects, suggesting that SIRT7‐associated YAP/ATP7A signalling contributes to Eriocitrin‐mediated cardioprotection. The therapeutic efficacy of Eriocitrin showed similar protective trends to tetrathiomolybdate, a copper chelator. These findings suggest that Eriocitrin alleviates experimental DCM in association with improved myocardial copper homeostasis and attenuation of cuproptosis‐associated molecular alterations, with SIRT7‐associated YAP/ATP7A signalling potentially contributing to these effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperDiabetic CardiomyopathiesDiabetes Mellitus, ExperimentalFlavonoidsAnimalsCuproptosisHomeostasisSirtuinsSignal TransductionMiceCopper-Transporting ATPasesMyocytes, CardiacMaleMice, Inbred C57BL

Stichwörter der Autor:innen

EriocitrinSIRT7copper homeostasiscuproptosisdiabetic cardiomyopathy

Substanzen

CopperSirtuinsCopper-Transporting ATPasesAtp7a protein, mouseFlavonoids

Autor:innen und Institutionen

  • Department of Anesthesiology, Sir Run Shaw Hospital, Zhejiang University School of Medicine, Zhejiang, China.
  • Department of Radiology, Shanghai Jiading District Anting Hospital, Shanghai, China.
  • Department of Functional Examination, Shanghai Jiading District Anting Hospital, Shanghai, China.
  • Cell Therapy Platform, Public Technology Platform, Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, China.
  • Department of Ultrasound Diagnosis, Shanghai Jiading District Anting Hospital, Shanghai, China.

ORCID-Profile: Zixia Fan

Zitieren

APA

Chen, L., Mao, S., Yu, Y., Zhang, D., & Fan, Z. (2026). Eriocitrin Attenuates Diabetic Cardiomyopathy by Regulating Copper Homeostasis and Cuproptosis‐Associated Pathways via SIRT7/YAP/ATP7A Signalling. Basic & Clinical Pharmacology & Toxicology, 139(4). https://doi.org/10.1111/bcpt.70301

Vancouver

Chen L, Mao S, Yu Y, Zhang D, Fan Z. Eriocitrin Attenuates Diabetic Cardiomyopathy by Regulating Copper Homeostasis and Cuproptosis‐Associated Pathways via SIRT7/YAP/ATP7A Signalling. Basic & Clinical Pharmacology & Toxicology. 2026;139(4). doi:10.1111/bcpt.70301

BibTeX
@article{Chen2026,
  author = {Chen, Lin and Mao, Sixin and Yu, Yan and Zhang, Dingyong and Fan, Zixia},
  title = {Eriocitrin Attenuates Diabetic Cardiomyopathy by Regulating Copper Homeostasis and Cuproptosis‐Associated Pathways via SIRT7/YAP/ATP7A Signalling},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  volume = {139},
  number = {4},
  doi = {10.1111/bcpt.70301}
}
Kostenlos starten →